These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30734643)

  • 1. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis.
    Andreu V; Larrea A; Rodriguez-Fernandez P; Alfaro S; Gracia B; Lucía A; Usón L; Gomez AC; Mendoza G; Lacoma A; Dominguez J; Prat C; Sebastian V; Ainsa JA; Arruebo M
    Nanomedicine (Lond); 2019 Mar; 14(6):707-726. PubMed ID: 30734643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
    Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
    Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-
    Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
    Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A
    Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
    Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
    Gajendiran M; Divakar S; Raaman N; Balasubramanian S
    Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice.
    Liang Q; Xiang H; Li X; Luo C; Ma X; Zhao W; Chen J; Tian Z; Li X; Song X
    Int J Nanomedicine; 2020; 15():7491-7507. PubMed ID: 33116484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery.
    Ismail R; Sovány T; Gácsi A; Ambrus R; Katona G; Imre N; Csóka I
    Pharm Res; 2019 May; 36(7):99. PubMed ID: 31087188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish.
    Vibe CB; Fenaroli F; Pires D; Wilson SR; Bogoeva V; Kalluru R; Speth M; Anes E; Griffiths G; Hildahl J
    Nanotoxicology; 2016 Aug; 10(6):680-8. PubMed ID: 26573343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis.
    Ellis T; Chiappi M; García-Trenco A; Al-Ejji M; Sarkar S; Georgiou TK; Shaffer MSP; Tetley TD; Schwander S; Ryan MP; Porter AE
    ACS Nano; 2018 Jun; 12(6):5228-5240. PubMed ID: 29767993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
    Jiang H; Li X; Xing Z; Niu Q; Xu J
    Curr Drug Deliv; 2023; 20(3):306-316. PubMed ID: 35546770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
    Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
    Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.
    Kim DH; Nguyen TN; Han YM; Tran P; Rho J; Lee JY; Son HY; Park JS
    Drug Deliv; 2021 Dec; 28(1):2268-2277. PubMed ID: 34668836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
    Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S
    Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microencapsulation of rifampicin for the prevention of endophthalmitis: In vitro release studies and antibacterial assessment.
    Lee MY; Bourgeois S; Almouazen E; Pelletier J; Renaud F; Fessi H; Kodjikian L
    Int J Pharm; 2016 May; 505(1-2):262-70. PubMed ID: 26997423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.